Recent Finacing
Recent Raise
Prytime Medical develops and commercializes minimally invasive REBOA catheters for truncal hemorrhage control, including ER-REBOA PLUS and the FDA-cleared pREBOA-PRO partial REBOA catheter used in 7,500 clinical cases.
Focus Areas
Total Raised
Funding round
See the team members at Prytime Medical Devices.
